PTEN mutations are one of the most common genetic alterations in GBM and are directly associated with malignant transformation and metastasis, but also noted in up to 40% of primary breast cancers associated with therapeutic resistance and a shorter patient overall survival [25,26,27,28,29]. Here, PTEN is linked to breast cancer.